Pre-operative cardiac workup after anthracycline-based neoadjuvant chemotherapy. Is it really necessary?

Annals of the Royal College of Surgeons of England

Volumn 93, Issue 2, 2011, Pages 127-129

  Shapiro, Ron ^a   Barsuk, Daphna ^a   Segev, Lior ^a   Shimon Paluch, Shani ^a   Berkenstadt, Haim ^a   Zippel, Douglas B ^a   Papa, Moshe Z ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Breast surgery; Cardiotoxicity; Neoadjuvant chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HUMAN; METHODOLOGY; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDY;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DOXORUBICIN; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDIES;

EID: 79952476636     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588411X12851639107836     Document Type: Article

References (13)

1. Weesner KM, Bledsoe M, Chauvenet A, Wofford M. Exercise echocardiography in the detection of anthracycline cardiotoxicity. Cancer 1991;68:435-8.
2. Shan K, Lincoff AM, Young JB. Anthracycline-induced cardiotoxicity. Ann Intern Med 1996;125:47-58.
3. Von Hoff DD, Layard MW, Basa P, Davis HL, Von Hoff AL, Rozencweig M et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 1979;91:710-7. (Pubitemid 10218041)
4. Levine MN, Bramwell VH, Pritchard KI, Norris BD, Shepherd LE, Abu-Zahra H et al. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1998;16:2651-8. (Pubitemid 28363028)
5. Basser L, Abraham R, To LB, Fox RM, Green MD. Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer. Ann Oncol 1999;10:53-8. (Pubitemid 29090592)
6. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER et al. Effects of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998;16:2672-85. (Pubitemid 28363030)
7. Papa MZ, Klein E, Davidson B, Karni T, Sperber F, Koller M et al. The effect of anesthesia type on needle localization breast biopsy: another point of view. Am J Surg 1996;171:242-3. (Pubitemid 26060172)
8. Torti FM, Bristow MR, Howes AE, Aston D, Stockdale FE, Carter SK et al. Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy. Ann Intern Med 1983;99:745-9. (Pubitemid 14248398)
9. Fumoleau P, Roché H, Kerbrat P, Bonneterre J, Romestaing P, Fargeot P et al; French Adjuvant Study Group. Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group results. Ann Oncol 2006;17:85-92. (Pubitemid 43033845)
10. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 2003;97:2869-79. (Pubitemid 36605157)
11. Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Natl Cancer Inst 2003;21:1431-9. (Pubitemid 46594092)
12. Giordano SH, Booser DJ, Murray JL, Ibrahim NK, Rahman ZU, Valero V et al. A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and oneor three-hour-infusion paclitaxel in patients with metastatic breast cancer. Clin Cancer Res 2002;8:3360-8. (Pubitemid 35340709)
13. Gianni L, Dombernowsky P, Sledge G, Martin M, Amadori D, Arbuck SG et al. Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancer. Ann Oncol 2001;12:1067-73. (Pubitemid 32834486)